A RCT of high-dose IFN induction followed by combination therapy with ribavirin in naive patients with chronic hepatitis C.

被引：0
|
作者：
Vaccaro, A [1 ]
Di Marco, V [1 ]
Ferraro, D [1 ]
Parisi, P [1 ]
Cappello, M [1 ]
Cino, N [1 ]
Di Stefano, R [1 ]
Almasio, PL [1 ]
Craxi, A [1 ]
机构：
[1] Univ Palermo, Palermo, Italy
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
815
引用
收藏
页码：363A / 363A
页数：1
相关论文
共 50 条
  • [41] High dose induction therapy with interferon alpha followed by combination therapy for naive hepatitis C patients - Results of a multicenter randomized controlled study.
    Kaiser, S
    Kreysel, C
    Zeitz, M
    Schneider, W
    Gregor, M
    HEPATOLOGY, 2000, 32 (04) : 561A - 561A
  • [42] High efficacy of combination therapy with pegylated interferon and ribavirin in hemophiliacs with chronic hepatitis C.
    Mancuso, ME
    Santagostino, E
    Rumi, MG
    Linari, S
    Coppola, A
    Rocino, A
    Iorio, A
    Dragani, A
    Barillari, G
    Tagariello, G
    Nicolin, R
    Colombo, M
    Mannucci, PM
    BLOOD, 2005, 106 (11) : 899A - 900A
  • [43] Efficacy and tolerability of consensus IFN and ribavirin combination therapy in naive patients affected by chronic hepatitis C with genotype 1 and high viral load.
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Cattaneo, C
    Bellobuono, A
    Ideo, G
    HEPATOLOGY, 2001, 34 (04) : 337A - 337A
  • [44] Treatment of chronic hepatitis C in patients who have failed to respond to IFN or IFN and ribavirin combination therapy
    Mazen Alsatie
    Paul Y. Kwo
    Current Hepatitis Reports, 2003, 2 (1) : 32 - 39
  • [45] High induction doses of interferon plus ribavirin followed by daily dosing with combination therapy in patients with chronic hepatitis C: An interim report.
    Conjeevaram, HS
    Madrigal, A
    Al-Saden, P
    Baker, AL
    HEPATOLOGY, 1999, 30 (04) : 634A - 634A
  • [46] Retreatment of IFN nonresponders (NR) or relapsers (REL) with chronic hepatitis C with high dose interferon (IFN) in combination with ribavirin
    Steindl-Munda, PJ
    Kopty, DC
    Ferenci, P
    Vogel, W
    Datz, C
    Brunner, H
    Strauber, R
    JOURNAL OF HEPATOLOGY, 2000, 32 : 103 - 103
  • [47] Efficacy in patients with dose reduction in combination therapy of peginterferon and ribavirin for chronic hepatitis c
    Arase, Yasuji
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Kawamura, Yusuke
    Suzuki, Yoshiyuki
    Kobayashi, Masahiro
    Akuta, Norio
    Hosaka, Tetsuya
    Yatsuji, Hiromi
    Hirakawa, Miharu
    Kobayashi, Mariko
    Ikeda, Kenji
    Kumada, Hiromitsu
    INTERVIROLOGY, 2008, 51 (01) : 1 - 6
  • [48] Efficacy of combination therapy using twice-a-day IFN-β followed by IFN-α for chronic hepatitis C.
    Chikazawa, H
    Fujiyama, S
    Tanaka, M
    Honda, Y
    Sugi, K
    Tomita, K
    HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [49] αIFN and Ribavirin combination therapy reduces the occurrence of breakthrough in chronic hepatitis C
    Bellobuono, A
    Tempini, S
    Idéo, GM
    Brasca, P
    Mondazzi, L
    Antonelli, G
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 111 - 111
  • [50] Effect of 12 month αIFN and Ribavirin combination therapy in chronic hepatitis C unresponsive to αIFN
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Idéo, GM
    Mondazzi, L
    Brasca, P
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
12345